đź’¨ Abstract
On May 7, 2025, EyePoint Pharmaceuticals (EYPT) announced a net loss of $45.2 million (65 cents per share) for Q1, meeting analyst expectations. Despite the loss, the company's revenue of $24.5 million exceeded forecasts, with analysts predicting only $5.5 million. This information was automatically generated based on data from Zacks Investment Research.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Thunder set NBA playoff record for first-half points with 87 vs. Denver in Game 2 of West semis -
Yankees rally past Padres 4-3 in 10 innings after breaking up Cease’s no-hit bid in 7th -
Marner scores tiebreaking goal as Maple Leafs beat Panthers 4-3 for 2-0 series lead -
Federal judge temporarily blocks Trump administration’s transit and homelessness grant conditions -
Prince George’s Community College’s garden is growing, in more ways than one -
Sánchez allows 1 hit, Turner, Stott and Harper combine for 6 RBIs in Phillies 7-0 win over Rays -
Sen. John Fetterman raises alarms with outburst at meeting with union officials, AP sources say -
What happened with the 5 police officers accused of crimes in Tyre Nichols’ fatal beating -
The top photos of the day by AP’s photojournalists -
Witt and Wacha lead Royals to 2-1 victory over White Sox -
Powered by MessengerX.io